Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Zarantonello

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
JHEP Reports : Innovation in Hepatology|July 22, 2024
Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre studySimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
Journal of Internal Medicine|November 20, 2023
Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survivalSimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
JHEP Reports : Innovation in Hepatology|March 14, 2026
The qEEG-TIPS score: Development of a predictive model for recurrent overt hepatic encephalopathy after elective TIPSDario Saltini, Lisa Zarantonello, Alberto Zanetto, et al.
Hepatology Communications|May 3, 2024
PHES scores have limited impact on the risk of overt HE in patients with minimal HESimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
The American Journal of Gastroenterology|March 20, 2023
Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter StudySimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
Journal of Hepatology|April 24, 2021
A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathySara Montagnese, Mette Lauridsen, Hendrik Vilstrup, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
JHEP Reports : Innovation in Hepatology|July 22, 2024
Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre studySimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
Journal of Internal Medicine|November 20, 2023
Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survivalSimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
JHEP Reports : Innovation in Hepatology|March 14, 2026
The qEEG-TIPS score: Development of a predictive model for recurrent overt hepatic encephalopathy after elective TIPSDario Saltini, Lisa Zarantonello, Alberto Zanetto, et al.
Hepatology Communications|May 3, 2024
PHES scores have limited impact on the risk of overt HE in patients with minimal HESimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
The American Journal of Gastroenterology|March 20, 2023
Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter StudySimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
Journal of Hepatology|April 24, 2021
A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathySara Montagnese, Mette Lauridsen, Hendrik Vilstrup, et al.
Pageof 4